Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
AmplifyBio Completes Acquisition of Intellectual Property to Offer Non-Viral Gene Editing Services for Clients
Thursday, July 13, 2023AmplifyBio a leading service provider for the commercialization of advanced modality therapeutics such as cell and gene therapies today announced the successful acquisition of a cuttingedge intellectual property IP that among other capabilities will...
22nd Century Group (XXII) Announces New Agreement with Hub, Inc. to Expand Midwest Distribution
Thursday, July 13, 2023nd Century Group Inc Nasdaq XXII a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness with reduced nicotine tobacco hempcannabis and hops today announced a new distribution agreement with Hub...
Neuraxpharm expands outside Europe into Brazil and Mexico
Wednesday, July 12, 2023Neuraxpharm Group Neuraxpharm a leading European specialty pharmaceutical company focused on the treatment of central nervous system CNS disorders today announces the establishment of affiliates in Brazil and Mexico the two largest pharmaceutical mar...
L7 Informatics Expands European Operations Strengthening Commitment to Pharmaceutical and Biotech Industries
Wednesday, July 12, 2023L Informatics Inc the leading provider of scientific solutions for research development manufacturing and quality control is delighted to announce the expansion of its European operations reinforcing its dedication to serving the pharmaceutical and b...
IAMA Therapeutics Announces Sponsored Research Agreement with The Sapienza University of Rome, Italy
Tuesday, July 11, 2023IAMA Therapeutics a pharmaceutical company focused on the discovery development and commercialization of novel medicines for children affected by brain disorders today announced a partnership with The Sapienza University of Rome Italy The planned tra...
European Commission approves Roche’s fixed-duration Columvi (glofitamab) for people with relapsed or refractory diffuse large B-cell lymphoma
Tuesday, July 11, 2023Roche SIX RO ROG OTCQX RHHBY announced today that the European Commission EC has granted conditional marketing authorisation for Columvi glofitamab for the treatment of adult patients with relapsed or refractory RR diffuse large Bcell lymphoma DLBCL...
Nanobiotix Announces License Agreement For Worldwide Co-development And Commercialization Of Potential First-in-class Radioenhancer Nbtxr3
Monday, July 10, 2023NANOBIOTIX Euronext NANO NASDAQ NBTX the Company a lateclinical stage biotechnology company pioneering physicsbased approaches to expand treatment possibilities for patients with cancer today announced a global licensing codevelopment and commercia...
FDA grants traditional approval for LEQEMBI® (lecanemab-irmb) for the treatment of Alzheimer's disease
Friday, July 07, 2023BioArctic ABs publ NASDAQ Stockholm BIOA B partner Eisai announced today that the US Food and Drug Administration FDA has approved the supplemental Biologics License Application sBLA supporting the traditional approval of LEQEMBI lecanemabirmb mgmL...
Carrick Therapeutics Announces Clinical Trial Collaboration with Arvinas and Pfizer to Evaluate Samuraciclib and Vepdegestrant Combination
Friday, July 07, 2023Carrick Therapeutics an oncologyfocused biopharmaceutical company discovering and developing highly differentiated therapies today announced a clinical trial collaboration and supply agreement with Arvinas Inc Nasdaq ARVN and Pfizer Inc NYSE PFE
Altamira Therapeutics Announces Collaboration with Heqet Therapeutics on Nanoparticle-Delivered Non-Coding RNAs for Cardiac Regeneration
Thursday, July 06, 2023Altamira Therapeutics Ltd Altamira or the Company NasdaqCYTO a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver today announced that it has entered into a collaboration and option agreement with...
